Society ❯ Corporate Ethics

Transparency

Accountability Investor Rights Governance Consumer Awareness Investor Relations Misleading Information Public Advocacy Financial Misconduct Financial Disclosures Stakeholder Trust Environmental Awareness Secrecy in Business Public Recognition Fraud Prevention

Corcept Faces Securities Class Action Over Relacorilant Disclosures as Firms Rally Investors Before April 21 Deadline

Plaintiffs say Corcept overstated relacorilant’s approval prospects in the face of FDA concerns.

Toyota Lifts Toyota Industries Buyout Offer to ¥20,600 as Elliott Agrees to Tender

Warren Confronts Skydance’s David Ellison on CBS, Elevating Fight Over Media Consolidation